With FDA 510(k) clearance for the MAGNETOM Vida with syngo MR XA11B on 18th January 2019, for the first time, the FDA has provided clearance for camera-based, prospective motion correction for MR imaging. The clearance includes the MPRAGE sequence and the fiducial markers for motion correction.
The Kinetic Sensor and associated prospective motion correction technologies are part of the Siemens MR BioMatrix portfolio, developed under a close collaboration between Siemens Healthineers and KinetiCor.
MPRAGE without (left) and with (right) prospective motion correction. Similar motion was detected for both scans. Images acquired on MAGNETOM Vida with Head/Neck 64. Courtesy of Siemens Healthineers.